"Answers in hours": A prospective clinical study using nanopore sequencing for bile duct cultures

Jennifer A Yonkus1, Emma Whittle2, Roberto Alva-Ruiz1

  • 1Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN.

Surgery
|January 2, 2022
PubMed
Abstract

Insights

Nanopore sequencing rapidly identifies microbes in bile samples from pancreatic surgery patients, offering broader insights than standard cultures. This technology can improve antibiotic stewardship by providing faster, more comprehensive results.

Area of Science:

  • Microbiology
  • Genomics
  • Surgical Infectious Diseases

Background:

  • Surgical site infections are a significant complication following pancreatic head resection.
  • Intraoperative bile cultures guide antibiotic therapy, but standard methods delay results.
  • Prolonged prophylactic antibiotics are often used due to slow culture turnaround times.

Purpose of the Study:

  • To investigate the feasibility of using nanopore sequencing for intraoperative bile sample analysis.
  • To compare nanopore sequencing with standard cultures for microbial profiling and antibiotic recommendations.
  • To assess the potential of nanopore sequencing to enhance antibiotic stewardship in pancreatic surgery.

Main Methods:

  • Intraoperative bile samples from patients undergoing pancreatic head resection were analyzed.
  • Microbial profiles were determined using both standard bacterial cultures and nanopore sequencing.
  • Time-to-result, organism yield, resistance patterns, and antibiotic recommendations were compared.

Main Results:

  • Nanopore sequencing detected more bacterial species and resistance genotypes than standard cultures.
  • Results from nanopore sequencing were significantly faster (8 hours vs. 98 hours).
  • Nanopore sequencing provided broader antimicrobial coverage recommendations in a majority of cases.

Conclusions:

  • Rapid microbial profiling via nanopore sequencing is feasible and offers comprehensive organism and resistance data.
  • Nanopore sequencing demonstrates a perfect negative predictive value, crucial for ruling out infection.
  • This technology holds promise for improving antibiotic stewardship, with a randomized trial planned.

Related Concept Videos